Saran Chhabra, PhD
About Saran Chhabra, PhD
Saran Chhabra, PhD, serves as the Executive Director and Head of Global Medical Writing & Clinical Trial Disclosure at Deciphera Pharmaceuticals. With extensive experience in medical writing across various organizations, he has held significant roles at Sunovion Pharmaceuticals, Deciphera Pharmaceuticals, ImmunoGen, Boston Scientific, and Wyeth.
Current Role at Deciphera Pharmaceuticals
Saran Chhabra serves as the Executive Director and Head of Global Medical Writing & Clinical Trial Disclosure at Deciphera Pharmaceuticals. In this role, which began in 2023, Chhabra oversees the strategic direction and management of medical writing and clinical trial disclosure activities. This position builds on previous experience within the company, where Chhabra held the role of Executive Director and Head of Medical Writing from 2022 to 2023.
Previous Experience in Medical Writing
Chhabra has extensive experience in medical writing, having worked in various capacities across multiple organizations. Prior to joining Deciphera Pharmaceuticals, Chhabra was the Senior Director and Head of Medical Writing at ImmunoGen, Inc. for six months in 2019. Additionally, Chhabra held the position of Senior Director and Head of Medical Writing at Deciphera Pharmaceuticals from 2019 to 2022. Earlier roles include Associate Director of Medical Writing at Sunovion Pharmaceuticals Inc. from 2007 to 2015 and Principal Clinical Writer at Wyeth from 2003 to 2006.
Educational Background
Saran Chhabra earned a PhD in Life Sciences from Jawaharlal Nehru University. Prior to this, Chhabra completed a Master of Science (MSc) in Zoology and a Bachelor of Science (BSc Hons) in Zoology, both from Delhi University. This educational foundation supports Chhabra's expertise in medical writing and clinical trial disclosure.
Career Timeline
Chhabra's career in medical writing spans several key positions. Starting as a Principal Medical Writer at Boston Scientific in 2007, Chhabra progressed to Manager of Medical Writing at Sunovion Pharmaceuticals Inc. from 2007 to 2009. Following this, Chhabra served as Associate Director at Sunovion until 2015. After a brief tenure at Wyeth, Chhabra joined Deciphera Pharmaceuticals in 2019 as Senior Director. Chhabra's career reflects a consistent focus on medical writing and clinical trial documentation.